Table 3.
Evaluation of changes in questionnaires’ score after 1 and 6 months (=positive value means tinnitus improvement)
| 1 month | 6 months | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| N | Mean | SD | Min. | Max. | N | Mean | SD | Min. | Max. | ||
| BDI | rTMS | 19 | 0.5 | 4.40 | −11 | 10 | 20 | 0.1 | 5.50 | −14 | 12 |
| Sham | 12 | −0.6 | 4.29 | −7 | 8 | 12 | 0.0 | 3.59 | −6 | 6 | |
| Medicament | 19 | −0.4 | 2.91 | −6 | 7 | 21 | 0.3 | 3.20 | −8 | 7 | |
| P = 0.681a | P = 0.9731a | ||||||||||
| THI | rTMS | 19 | 4.5 | 11.72 | −14 | 38 | 20 | 9.1 | 11.85 | −12 | 36 |
| Sham | 12 | 0.2 | 7.98 | −20 | 10 | 12 | 4.3 | 9.41 | −6 | 30 | |
| Medicament | 20 | −0.7 | 14.90 | −35 | 50 | 21 | 1.4 | 12.39 | −10 | 50 | |
| P = 0.3945a | P = 0.1111a | ||||||||||
| THQ | rTMS | 19 | 1.5 | 8.52 | −14.8 | 19.8 | 20 | 6.1 | 12.55 | −12.9 | 25.9 |
| Sham | 12 | −1.1 | 8.75 | −17.8 | 16.3 | 12 | 2.8 | 6.34 | −10.8 | 11.9 | |
| Medicament | 20 | 0.1 | 6.23 | −11.1 | 10.3 | 21 | −1.2 | 11.99 | −27 | 37.1 | |
| P = 0.6489a | P = 0.1272a | ||||||||||
| TRQ | rTMS | 19 | 4.9 | 7.04 | −4 | 21 | 20 | 9.1 | 11.55 | −5 | 33 |
| Sham | 12 | 1.5 | 6.69 | −7 | 13 | 12 | 4.7 | 8.24 | −10 | 22 | |
| Medicament | 20 | 1.4 | 6.27 | −12 | 14 | 21 | 1.7 | 8.84 | −21 | 25 | |
| P = 0.1964a | P = 0.0641a | ||||||||||
BDI, Beck Depression Inventory; rTMS, repetitive transcranial magnetic stimulation; SD, standard deviation; THI, Tinnitus Handicap Inventory; THQ, Tinnitus Handicap Questionnaire; TRQ, Tinnitus Reaction Questionnaire.
a
One‐way analysis of variance for repeated measures.